Literature DB >> 14994182

Use of nesiritide (human B-type natriuretic peptide) in infants following cardiac surgery.

J M Simsic1, V S Reddy, K R Kanter, P M Kirshbom, J M Forbess.   

Abstract

We report the use of nesiritide in two infants following cardiac surgery. Both infants had increased intracardiac filling pressures postoperatively, despite traditional afterload reduction and diuretics. Both infants demonstrated clinical improvement with nesiritide therapy. There is currently limited data available describing the use of nesiritide in infants.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14994182     DOI： 10.1007/s00246-003-0680-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  5 in total

1.  Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.

Authors:  W T Abraham; B D Lowes; D A Ferguson; J Odom; J K Kim; A D Robertson; M R Bristow; R W Schrier
Journal:  J Card Fail       Date:  1998-03       Impact factor: 5.712

2.  Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.

Authors:  R M Mills; T H LeJemtel; D P Horton; C Liang; R Lang; M A Silver; C Lui; K Chatterjee
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

3.  Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

Authors:  L S Marcus; D Hart; M Packer; M Yushak; N Medina; R S Danziger; D F Heitjan; S D Katz
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

4.  Natriuretic peptide system in human heart failure.

Authors:  C M Wei; D M Heublein; M A Perrella; A Lerman; R J Rodeheffer; C G McGregor; W D Edwards; H V Schaff; J C Burnett
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

5.  Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.

Authors:  S J Holmes; E A Espiner; A M Richards; T G Yandle; C Frampton
Journal:  J Clin Endocrinol Metab       Date:  1993-01       Impact factor: 5.958
  5 in total
  2 in total

1.  Nesiritide improves hemodynamics in children with dilated cardiomyopathy: a pilot study.

Authors:  Sarina K Behera; Jennifer C Zuccaro; Glenn T Wetzel; Juan C Alejos
Journal:  Pediatr Cardiol       Date:  2008-08-15       Impact factor: 1.655

Review 2.  Future pharmacologic agents for treatment of heart failure in children.

Authors:  Brady S Moffett; Anthony C Chang
Journal:  Pediatr Cardiol       Date:  2006-08-23       Impact factor: 1.655
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.